Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Respiratory Research

Table 2 Baseline-adjusted mean differences between aclidinium and placebo on lung function parameters at all measured time points throughout the 52-week studies

*p < 0.05; ^§p < 0.01; ^†p < 0.001; ^‡p < 0.0001.
Data are reported as the minimum and maximum values over the treatment period; the indicated p-values apply throughout the stated range.
FEV₁: forced expiratory volume in 1 second; AUC_{(0-3 h)}: area under the curve from 0 to 3 h post-dose; FVC: forced vital capacity; IC: inspiratory capacity; PEF: peak expiratory flow.

ISSN: 1465-993X